Terms: = Germ cell tumor AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
264 results:
1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
2. Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis.
Chen W; Hao P; Song Q; Feng X; Zhao X; Wu J; Gong Z; Zhang J; Fu X; Wang X
Metab Brain Dis; 2024 Apr; 39(4):625-633. PubMed ID: 38416338
[TBL] [Abstract] [Full Text] [Related]
3. Distinguishing IDH mutation status in gliomas using FTIR-atr spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.
Kino S; Kanamori M; Shimoda Y; Niizuma K; Endo H; Matsuura Y
BMC Cancer; 2024 Feb; 24(1):222. PubMed ID: 38365669
[TBL] [Abstract] [Full Text] [Related]
4. Simulated microgravity induces DNA damage concurrent with impairment of DNA repair and activation of cell-type specific DNA damage response in microglial and glioblastoma cells.
Singh R; Jaiswal A; Singh RP
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119679. PubMed ID: 38272357
[TBL] [Abstract] [Full Text] [Related]
5. atr inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
Oncotarget; 2024 Jan; 15():1-18. PubMed ID: 38227740
[TBL] [Abstract] [Full Text] [Related]
6. ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic atr inhibition.
Borenäs M; Umapathy G; Lind DE; Lai WY; Guan J; Johansson J; Jennische E; Schmidt A; Kurhe Y; Gabre JL; Aniszewska A; Strömberg A; Bemark M; Hall MN; Eynden JVD; Hallberg B; Palmer RH
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2315242121. PubMed ID: 38154064
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of chitosan nanoparticles containing Lippia citriodora essential oil and citral on the induction of apoptosis in A375 melanoma cells.
Karimivaselabadi A; Osanloo M; Ghanbariasad A; Zarenezhad E; Hosseini H
BMC Complement Med Ther; 2023 Dec; 23(1):435. PubMed ID: 38041055
[TBL] [Abstract] [Full Text] [Related]
8. Comparison effects of Ferula gummosa essential oil and Beta-pinene Alginate nanoparticles on human melanoma and breast cancer cells proliferation and apoptotic index in short term normobaric hyperoxic model.
Osanloo M; Pishamad S; Ghanbariasad A; Zarenezhad E; Alipanah M; Alipanah H
BMC Complement Med Ther; 2023 Nov; 23(1):428. PubMed ID: 38017466
[TBL] [Abstract] [Full Text] [Related]
9. Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Weber M; Pettersson O; Seifert R; Schaarschmidt BM; Fendler WP; Rischpler C; Lahner H; Herrmann K; Sundin A
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):841-851. PubMed ID: 37947848
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of atr opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis.
Derby SJ; Dutton L; Strathdee KE; Stevenson K; Koessinger A; Jackson M; Tian Y; Yu W; Mclay K; Misquitta J; Alsharif S; Clarke CJ; Gilmour L; Thomason P; McGhee E; McGarrity-Cottrell CL; Vanderlinden A; Collis SJ; Rominyi O; Lemgruber L; Solecki G; Olson M; Winkler F; Carlin LM; Heiland DH; Inman GJ; Chalmers AJ; Norman JC; Carruthers R; Birch JL
Neuro Oncol; 2024 Apr; 26(4):625-639. PubMed ID: 37936324
[TBL] [Abstract] [Full Text] [Related]
11. DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
Vanderlinden A; Jones CG; Myers KN; Rominiyi O; Collis SJ
Br J Cancer; 2023 Nov; 129(11):1829-1840. PubMed ID: 37777579
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract] [Full Text] [Related]
13. Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma.
Cescon M; Rampazzo E; Bresolin S; Da Ros F; Manfreda L; Cani A; Della Puppa A; Braghetta P; Bonaldo P; Persano L
Cell Mol Life Sci; 2023 Jul; 80(8):233. PubMed ID: 37505240
[TBL] [Abstract] [Full Text] [Related]
14. Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis.
Araujo Moura AW; da Silva Rodrigues S; de Oliveira TF; Lobato BM; Pereira Cerize NN; Léo P
J Oncol Pharm Pract; 2023 Oct; 29(7):1736-1747. PubMed ID: 37503551
[TBL] [Abstract] [Full Text] [Related]
15. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
[TBL] [Abstract] [Full Text] [Related]
16. A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database.
Chen H; Pu S; Wang L; Zhang H; Yan Y; He J; Zhang J
Sci Rep; 2023 Jul; 13(1):10704. PubMed ID: 37400489
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors for cerebrospinal fluid leak after extended endoscopic endonasal surgery for adult patients with craniopharyngiomas: a multivariate analysis of 364 cases.
Qiao N; Li C; Liu F; Ru S; Cai K; Jia Y; Cao L; Liu C; Zhang Y; Gui S
J Neurosurg; 2024 Jan; 140(1):47-58. PubMed ID: 37382333
[TBL] [Abstract] [Full Text] [Related]
18. Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.
Sassi A; Fredon M; Cotte AK; Fuselier C; Schneider C; Martiny L; Monchaud D; Chekir-Ghedira L; Aires V; Delmas D
Cells; 2023 Jun; 12(12):. PubMed ID: 37371032
[TBL] [Abstract] [Full Text] [Related]
19. Enhancer-driven transcription of MCM8 by E2F4 promotes atr pathway activation and glioma stem cell characteristics.
Sun YM; Zhang YM; Shi HL; Yang S; Zhao YL; Liu HJ; Li C; Liu HL; Yang JP; Song J; Sun GZ; Yang JK
Hereditas; 2023 Jun; 160(1):29. PubMed ID: 37349788
[TBL] [Abstract] [Full Text] [Related]
20. Thiol functionalised gold nanoparticles loaded with methotrexate for cancer treatment: From synthesis to in vitro studies on neuroblastoma cell lines.
Salamone TA; Rutigliano L; Pennacchi B; Cerra S; Matassa R; Nottola S; Sciubba F; Battocchio C; Marsotto M; Del Giudice A; Chumakov A; Davydok A; Grigorian S; Canettieri G; Agostinelli E; Fratoddi I
J Colloid Interface Sci; 2023 Nov; 649():264-278. PubMed ID: 37348346
[TBL] [Abstract] [Full Text] [Related]
[Next]
